NOVIGENIX: Funding, Investors & Team (Sep 2026)
Dedicated to improving illness management and patient outcomes, Novigenix is a Swiss precision medicine firm that specializes in ImmunoTranscriptomic solutions for disease identification, therapy optimization, and disease recurrence monitoring. The Novigenix proprietary LITOseek platform integrates patient multi-omics data, advanced Machine Learning, and artificial intelligence approaches to map the immune system's response to the onset and progression of disease and to provide precise solutions and actionable insights for optimizing the therapeutic course of patients. Our present product range comprises medication optimization solutions for the management of cancer patients, patient stratification solutions in the field of immuno-oncology, early detection and recurrence monitoring for colorectal cancer, and more.
NOVIGENIX has raised $20.0M across 1 funding round on record, the most recent a Series B of $20.0M announced in Nov 2022.
That round is above the $5.5M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
NOVIGENIX Company Profile and Key Stats
Latest funding round on record: Nov 2022.
NOVIGENIX Funding Rounds
NOVIGENIX Founders and Leadership Team
Contact details for the NOVIGENIX team: 1 of 1 has an email address on file.
Start 14-day free trial →NOVIGENIX Funding Compared to Other Artificial Intelligence Startups
NOVIGENIX's latest round of $20.0M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NOVIGENIX in Artificial Intelligence and Epalinges
Companies Similar to NOVIGENIX
At SUIND, our goal is to utilize advanced technology to enhance the productivity and ecological impact of…
Established in 2018, Aktiia, now operating under the name Hilo, aims to revolutionize the measurement and…
Anyway Systems is an IT company that develops AI deployment software for organizations.
Rflect helps universities protect their business model in the age of AI by training the human skills machines…
Computer Vision develops artificial intelligence software for medical imaging with a focus on radiology and…
Expert in AI-generated multi-marker algorithms. First product launched (Software as Medical Device) to…
Hephaistos develops AI-based systems to design new enzymes from scratch for use in chemical and industrial…
AVIAN is an industrial AI business that creates temperature monitoring and predictive safety systems for…
Gravit Open Network is a distributed infrastructure for epistemic execution and verifiable knowledge. It…
Moonlight AI empowers pathologists and hematologists to make therapeutic decisions backed by genomic insight.…
Newborns’ sounds of cries carry a wealth of information about their health, needs and emotions – including…
KEMARO GmbH, headquartered in Eschlikon, Switzerland, was founded in August 2016 by three engineers…
NOVIGENIX Funding FAQs
What does NOVIGENIX do?
Dedicated to improving illness management and patient outcomes, Novigenix is a Swiss precision medicine firm that specializes in ImmunoTranscriptomic solutions for disease identification, therapy optimization, and disease recurrence monitoring. The Novigenix proprietary LITOseek platform integrates patient multi-omics data, advanced Machine Learning, and artificial intelligence approaches to map the immune system's response to the onset and progression of disease and to provide precise solutions and actionable insights for optimizing the therapeutic course of patients. Our present product range comprises medication optimization solutions for the management of cancer patients, patient stratification solutions in the field of immuno-oncology, early detection and recurrence monitoring for colorectal cancer, and more.
How much funding has NOVIGENIX raised?
NOVIGENIX has raised $20.0M across 1 round on record. The most recent is a Series B of $20.0M announced in Nov 2022.
When did NOVIGENIX last raise funding?
NOVIGENIX's most recent funding round on record is a Series B of $20.0M, announced in Nov 2022.
Who founded NOVIGENIX?
FundedIQ lists Sahar Hosseinian (Founder) at NOVIGENIX.
Where is NOVIGENIX headquartered?
NOVIGENIX is based in Epalinges, Vaud, Switzerland.
How many employees does NOVIGENIX have?
NOVIGENIX is in the 11-50 employee band.
How does NOVIGENIX's funding compare to other Artificial Intelligence startups?
NOVIGENIX's latest round of $20.0M is above the $5.5M median round size for Artificial Intelligence companies on FundedIQ across 7,233 tracked companies over the last two years.
About FundedIQ's NOVIGENIX Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NOVIGENIX is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.